Just like our name “Quan” (meaning “Fountain／Spring” in Chinese), we discover, incubate and grow next-generation life sciences companies. Our unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Our portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significant value to patients. In addition, we are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China.
Empowered by strong expertise in both science and business, our investment professionals are able to identify and nurture the next generation of great companies. We are deeply involved in company building and hands-on to support strategy, operation, and development. We contribute broad networks to bridge and smooth companies’ transformation between different development stages, and maximize the company value across value chain and varying geographies.
We identify, incubate and invest in innovative early and growth stage companies globally and in China, with focus on:
We provide “smart capital” that brings:
Founding Managing Director
Samantha Du is Founding Managing Director of Quan Capital. During her career, she has been a successful drug developer, entrepreneur, investor and an overall industry leader in China, recognized for her wide influence on healthcare policies and for her work with various government bodies in China.